Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19
Álvaro Aparisi, Carolina Iglesias-Echeverría, Cristina Ybarra-Falcón, Iván Cusácovich, Aitor Uribarri, Mario García‐Gómez, Raquel Ladrón, Raúl Fuertes, Jordi Candela, Javier Tobar, Williams Hinojosa, Carlos Dueñas, Roberto González, Leonor Nogales, Dolores Calvo, Manuel Carrasco‐Moraleja, J. Alberto San Román, Ignacio J. Amat‐Santos, David Andaluz‐Ojeda
Topics & Concepts
MedicineHazard ratioInternal medicineConfidence intervalGastroenterologyRetrospective cohort studyCholesterolCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLipoproteins and Cardiovascular HealthHIV-related health complications and treatments